Financials data is unavailable for this security.
Cash flow in SEKView more
In 2023, cash reserves at Abera Bioscience AB fell by 12.14m. Cash Flow from Financing totalled 5.60m or -- of revenues. In addition the company used 17.71m for operations while cash used for investing totalled 25.00k.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.5733 |
---|---|
Tangible book value per share | 0.4504 |
More ▼
Balance sheet in SEKView more
Current ratio | 3.83 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼